Pharma Fridays – February 16, 2024

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Medicare Coverage Significantly Expanded for the Eversense E3 CGM System On February 12, Ascensia Diabetes Care, announced that Medicare has significantly expanded access to the Eversense E3 CGM System with the implementation of Local Coverage Determinations providing access to implantable CGM […]

To view the full Member Resource, please Log in


TOPICS IN THIS ARTICLE:

Share this article